Metraipolis › archive › dc_02dd938fb7cb
Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41019979
- DOI
- 10.20517/cdr.2025.133
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T01:44:40.147Z
- SHA-256 of the archived text
36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434- Stable URL of this page
https://metraipolis.com/documento/dc_02dd938fb7cb
How to cite
Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979 — Europe PMC (en), https://europepmc.org/article/MED/41019979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_02dd938fb7cb (Metraipolis archive dc_02dd938fb7cb, sha256 36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434)
BibTeX
@misc{dc02dd938fb7cb,
title = {Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with… — Europe PMC PMID:41019979},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41019979},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_02dd938fb7cb; sha256 36e8380035f0358a43485c1cb78ec14388b3822b2bae4ea1cf380e7d95178434},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41019979. Agents can read the archived copy with the MCP tool read_document.